Publisher of the most cited open-access journals in their fields.
We are pleased to announce a launch of the first Research Topic in the Regulatory Science section titled “Public-Private Partnerships as drivers of innovation in healthcare.” This Research Topic is edited by the Field Chief Editor Prof. Michel Goldman with support from Dr. Hilde Stevens and is now open for submissions. We look forward to your paper.
Frontiers in Medicine is a peer-reviewed Open Access journal, providing a unique vehicle for communicating to a broad audience the latest advances in key areas of medicine. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world
All manuscripts submitted to Frontiers in Medicine that have been conducted in human subjects must conform with current regulations and the Declaration of Helsinki. Ethics committee approval and informed patient consent are required for studies involving human subjects. Ethics committee approval is also needed for studies involving animals. Phase I - Phase IV clinical trials submitted for publication in Frontiers in Medicine must have been registered with an appropriate public trials registry at the time or before the first patient enrolment. The information on the clinical trial registration (Unique Identifier and URL) must be included in the abstract. Authors are required to disclose all apparent or potential conflicts of interest according to the ICMJE guidelines and those of Frontiers. Frontiers endeavors to follow the guidelines and best practice recommendations published by the Committee on Publication Ethics (COPE). Authors should refer to the author guidelines for full details.
Frontiers in Medicine is member of the Committee on Publication Ethics.
Short Name: Front. Med.
Electronic ISSN: 2296-858X
Indexed in: PubMed, PubMed Central, Google Scholar, DOAJ
PMCID: all published articles receive a PMCID
Frontiers in Medicine is composed of the following Specialty Sections:
The specialty sections of Frontiers in Medicine welcome submission of the following article types: Book Review, Case Report, Clinical Study Protocol, Clinical Trial, Community Case Study, Correction, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Technology Report, Protocols, Curriculum, Instruction, and Pedagogy and Addendum.
When submitting a manuscript to Frontiers in Medicine, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.
Articles published in the specialty sections above will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in the Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Medicine.